A Successful Presence at CPHI Milan 2024, Leading the European API & Intermediates Market
As a leading API and intermediates manufacturer from India, Maithili Life Sciences proudly participated in CPHI Milan 2024, where we showcased our commitment to delivering high-quality Active Pharmaceutical Ingredients (APIs) and intermediates to the European market. Our extensive product portfolio, regulatory compliance, and innovative approach make us a go-to partner for European pharmaceutical companies.
Strengthening Our Role as a Trusted API & Intermediates Supplier in Europe
At CPHI Milan 2024, held from October 8th to 10th, Maithili Life Sciences stood out as a key player in the pharmaceutical supply chain, representing India’s growing role in the global API market. With Europe being one of the most stringent regulatory regions, our participation emphasized our capability to meet the EU-GMP and USFDA standards, reinforcing our reputation for delivering high-quality, compliant APIs.
Why European Companies Choose Maithili Life Sciences
Commitment to Quality: Maithili Life Sciences is dedicated to maintaining the highest quality standards across our entire product line, making us a reliable partner for pharmaceutical companies across Europe.
Cost-Effective Solutions: Our ability to manufacture APIs in India allows us to provide cost-effective solutions while maintaining superior quality, giving European companies a competitive edge.
Regulatory Support: We assist our clients by ensuring that all our products meet international regulatory standards, simplifying the approval process in Europe and other regulated markets.
Sustainability and Innovation: Our commitment to sustainable manufacturing practices and innovative solutions ensures that we not only meet the current demands of the industry but are also prepared for future needs.
Our API Product Range for the European Market
At CPHI Milan, we showcased our extensive API portfolio, which includes:
- Azilsartan Medoxomil Potassium Salt: An angiotensin II receptor antagonist used to treat high blood pressure.
- Benazepril HCl: An ACE inhibitor for treating hypertension.
- Irbesartan: Used to treat high blood pressure and diabetic nephropathy.
- Nebivolol HCl: A beta-blocker that treats high blood pressure.
- Telmisartan: An angiotensin receptor blocker (ARB) for managing hypertension.
- Brivaracetam: Used as an anticonvulsant for epilepsy.
- Modafinil: Promotes wakefulness in conditions like narcolepsy.
- Rasagiline Mesylate: Used in the treatment of Parkinson’s disease.
- Trazodone: An antidepressant used for major depressive disorder.
- Ornidazole: An antibiotic used to treat infections caused by anaerobic bacteria and protozoa.
- Favipiravir: An antiviral used to treat influenza and COVID-19.
- Voriconazole: An antifungal medication for serious fungal infections.
- Etoricoxib: A COX-2 inhibitor for osteoarthritis and rheumatoid arthritis.
- Zaltoprofen: A non-steroidal anti-inflammatory drug (NSAID).
- Cabergoline Intermediates: Used in the treatment of hyperprolactinemia and pituitary tumors.
- Dabigatran Etexilate Mesylate: An anticoagulant used to prevent strokes and blood clots.
- Darolutamide Intermediates: Used in the treatment of non-metastatic castration-resistant prostate cancer.
- Minoxidil: Primarily used for its ability to promote hair growth.
- Dapoxetine HCl: Used for treating premature ejaculation.
- Solifenacin Succinate: Used to treat overactive bladder.
- Sumatriptan Succinate: For the treatment of migraine headaches.
- Tadalafil: Used to treat erectile dysfunction and benign prostatic hyperplasia.
- Tamsulosin: Treats benign prostatic hyperplasia.
- Ticagrelor: An antiplatelet medication to reduce cardiovascular events.
- Torsemide: A diuretic for treating edema and hypertension.
- Sildenafil: Treats erectile dysfunction and pulmonary arterial hypertension.
- Vardenafil: Used to treat erectile dysfunction.
These APIs cater to the growing demand in Europe for high-quality, innovative pharmaceutical ingredients, allowing us to position ourselves as a top API supplier to Europe.
How We are Leading the European Market
As a trusted API supplier to Europe, we continue to build partnerships that bridge the gap between Indian API manufacturers and European pharmaceutical companies. Our approach focuses on:
Diverse Product Portfolio: We offer APIs and intermediates across a wide range of therapeutic categories, ensuring that we meet the varied needs of the European pharmaceutical industry.
Regulatory Excellence: Our products comply with stringent international standards like EU-GMP, ensuring that our APIs meet European regulations for quality and safety.
Focused Innovation: We are continually investing in R&D to create new and improved APIs that cater to emerging demands, particularly in Europe’s fast-evolving pharmaceutical market.
The Impact of CPHI Milan on Our European Growth
CPHI Milan 2024 provided us with a valuable platform to further solidify our position in the European API market. The event attracted a wide range of pharmaceutical professionals and decision-makers, allowing us to forge new partnerships and strengthen existing relationships. Our booth was a hub of activity, with visitors eager to learn more about our offerings and discuss potential collaborations.
Our success at CPHI Milan reinforces Maithili Life Sciences’ commitment to becoming a premier API manufacturer in Europe. As we continue to expand our presence in the region, our focus remains on delivering innovative, high-quality, and cost-effective solutions to our partners.
Looking Ahead: Our Continued Commitment to Europe
Following the success of CPHI Milan, Maithili Life Sciences is excited to continue expanding in the European market. We are committed to being a trusted partner for European pharmaceutical companies, providing them with the high-quality APIs they need to produce essential medicines.
Our next steps include further engagement in Europe through upcoming events, strengthening our partnerships, and continuously enhancing our product portfolio to meet the region’s evolving pharmaceutical needs.
Contact Us
For more information about Maithili Life Sciences and our extensive range of APIs and intermediates, please contact us at [email protected] or visit our website www.maithililifesciences.com.
